Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Pavlína, Lisá"'
Autor:
Marianna Štefániková, Martina Doubková, Petra Ovesná, Martina Šterclová, Ladislav Lacina, Monika Žurková, Martina Plačková, Vladimír Bartoš, Ivana Janíčková, Radka Bittenglová, Jan Anton, Ľubica Sýkorová, Vladimíra Lošťáková, Pavlína Musilová, Hana Šuldová, Radka Mokošová, Jurij Didyk, Lenka Šišáková, Pavlína Lisá, Jaroslav Lněnička, Hana Dařičková, Daniel Doležel, Jana Pšikalová, Richard Tyl, Renata Králová, Martina Koziar Vašáková
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Introduction The antifibrotic drug nintedanib is used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the effect of nintedanib on antifibrotic treatment outcome in real-world cohorts of Czech EMPIRE registry. Patients/m
Externí odkaz:
https://doaj.org/article/354e93acae574d0789b4d40b679b4189
Autor:
Imrich Jonner, V. Lostakova, Małgorzata Sobiecka, F. Petrik, Peter Paluch, Martina Plačková, A. Jakic, J. Lnenicka, Štefan Tóth, Hana Suldova, T. Tran, Ladislav Dušek, Martina Sterclova, A. Szymanowska-Narioch, Aleksander Kania, M.J. Studnicka, Jan Anton, T. Stachura, Renata Králová, Pavlina Musilova, Richard Tyl, Mordechai R. Kramer, Marta Hájková, Ladislav Lacina, Martina Doubková, T. Pejcic, Marina Roksandic Milenkovic, L. Borucki, J. Plutinsky, V. Vucinic-Mihailovic, Margita Bučeková, Robert Slivka, Imre Lajkó, Pawel Sliwinski, Sebastian Majewski, A. Nowicka, Bohumil Matula, S. Mladinov, Zoltán Balikó, Ilona Binková, Anikó Bohács, Veronika Müller, P. Jurek, Natalia Stoeva, V. Rihak, Lenka Šišková, Radka Bittenglova, Pavlína Lisá, T. Snizek, Vladimir Bartos, R. Mokosova, Mária Szilasi, S. Suissa, T. R. Petkovic, Zsuzsanna Szalai, D. Jovanovic, Štefan Laššán, D. Dolezal, H. Hortvikova, Nesrin Mogulkoc, Miklós Zsiray, M. Zurkova, Beata Zolnowska, Martina Vasakova, Jana Psikalova, P. Reiterer, Katarzyna Lewandowska, Marzena Trzaska-Sobczak, Jasna Tekavec-Trkanjec, M. Martusewia-Boros, Karel Hejduk, R. Hrdina, Jiří Homolka, R. Vysehradsky
Publikováno v:
Respiratory Research, Vol 21, Iss 1, Pp 1-9 (2020)
Respiratory Research
Respiratory Research
Background Several registries of idiopathic pulmonary fibrosis (IPF) have been established to better understand its natural history, though their size and duration of follow-up are limited. Here, we describe the large European MultiPartner IPF Regist
Autor:
Vladimira Lostakova, Radka Bittenglova, Simona Littnerová, Pavlína Lisá, Eva Kriegova, Tomas Snizek, Hana Suldova, Michael Doubek, Martina Plačková, Martina Sterclova, Pavlina Musilova, Martina Vasakova, Lenka Šišková, Vladimir Bartos, Martina Doubková, Jana Psikalova, Petra Schneiderova, Monika Zurkova
Publikováno v:
Ther Adv Respir Dis
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Therapeutic Advances in Respiratory Disease, Vol 15 (2021)
Background: The antifibrotic drugs nintedanib and pirfenidone are used for the treatment of idiopathic pulmonary fibrosis (IPF). We analysed the association of common profibrotic polymorphisms in MUC5B (mucin 5B, rs35705950) and DSP (desmoplakin, rs2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::085ba847fd6bdfb3daff573e1c43b896
https://europepmc.org/articles/PMC8442489/
https://europepmc.org/articles/PMC8442489/
Autor:
Martina Vasakova, Hana Suldova, Martina Sterclova, Radka Bittenglova, Martina Doubková, Petra Schneiderova, Jana Psikalova, Vladimir Bartos, Michael Doubek, Monika Zurkova, Martina Plačková, Lenka Šišková, Pavlina Musilova, Vladimira Lostakova, Pavlína Lisá, Eva Kriegová, Tomas Snizek, Simona Littnerová
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97e706cfc0dd3b1bd41462f70a30efff
https://doi.org/10.1177/17534666211042529/v2/response1
https://doi.org/10.1177/17534666211042529/v2/response1
Autor:
Lenka Šišková, Veronika Müller, Jana Psikalova, Vladimíra Lošťáková, Robert Slivka, Michal Svoboda, Anikó Bohács, Miklós Zsiray, Jan Kus, Jan Anton, Ladislav Lacina, Jaroslav Lněnička, Mária Szilasi, Marzena Trzaska-Sobczak, Margita Bučeková, Robert Vyšehradský, Peter Paluch, Zoltán Balikó, Imrich Jonner, Katarzyna Lewandowska, Daniel Doležal, Renata Králová, Martina Doubková, Vladimir Bartos, Richard Tyl, Zsuzsanna Szalai, Imre Lajkó, Amelia Szymanowska-Narloch, Štefan Laššán, Beata Zolnowska, Pawel Sliwinski, Martina Vasakova, Jasna Tekavec-Trkanjec, Marina Roksandic Milenkovic, Bohumil Matula, Małgorzata Sobiecka, Nesrin Mogulkoc, Pavlína Lisá, Marta Hájková, Jana Strenková, Sebastian Majewski, D. Jovanovic, Štefan Tóth, Jiří Homolka, František Petřík, Pavlina Musilova, Tomáš Snížek, Radka Bittenglova, Martina Plačková, Hana Suldova, Ján Plutinský, Monika Žurková, Vladimír Řihák, Jan Kervitzer, Magdalena Martusewicz-Boros, Ilona Binková, Martina Sterclova
Publikováno v:
Diffuse Parenchymal Lung Disease.
Most patients with IPF have comorbidities, which affect functional status, quality of life and survival. Our study aims are to analyze comorbidities in a series of 1210 IPF patients from the EMPIRE registry (European Multipartner IPF registry). Comor
Autor:
Ladislav Lacina, Bučeková Bučeková, Jaroslav Lněnička, Ján Plutinský, František Petřík, Daniel Doležal, Pavlina Musilova, Vladimír Řihák, Jana Psikalova, Pavlína Lisá, Ilona Binková, Štefan Laššán, Vladimíra Lošťáková, Martina Sterclova, Veronika Müller, Imrich Jonner, Małgorzata Sobiecka, Miklós Zsiray, Jan Kervitzer, Martina Plačková, Radka Bittenglova, Štefan Tóth, Magdalena Martusewicz-Boros, Robert Vyšehradský, Jasna Tekavec-Trkanje, Zoltán Balikó, Dragana Jovanovic, Nesrin Mogulkoc, Jan Kus, Marzena Trzaska-Sobczak, Monika Žurková, Pawel Sliwinski, Katarzyna Lewandowska, Robert Slivka, Michal Svoboda, Anikó Bohács, Vladimir Bartos, Jiří Homolka, Jan Anton, Lenka Šišková, Sebastian Majewski, Marta Hájková, Beata Zolnowska, Martina Vasakova, Marina Roksandic Milenkovic, Amelia Szymanowska-Narloch, Tomáš Snížek, Imre Lajkó, Jana Strenková, Peter Paluch, Renata Králová, Bohumil Matula, Richard Tyl, Martina Doubková, Mária Szilasi, Hana Suldova, Zsuzsanna Szalai
Publikováno v:
Diffuse Parenchymal Lung Disease.
Key feature of IPF is decline in forced vital capacity (FVC) and CO diffusion (DLco), but data on clinical determinants of this change in patients who have established disease are scarce. For a given patient it is unknown if different natural histori
Autor:
Miklós Zsiray, Imrich Jonner, Katarzyna Lewandowska, Peter Paluch, Vladimíra Lošťáková, Štefan Laššán, Jan Kervitzer, Bohumil Matula, Robert Vyšehradský, Małgorzata Sobiecka, Marzena Trzaska-Sobczak, Imre Lajkó, Robert Slivka, Michal Svoboda, Štefan Tóth, Pavlína Lisá, Jan Anton, Anikó Bohács, Magdalena Martusewicz-Boros, Mária Szilasi, Zoltán Balikó, Renata Králová, Richard Tyl, Nesrin Mogulkoc, Ladislav Lacina, Marta Hájková, Jasna Tekavec-Trkanjec, Jan Kus, Beata Zolnowska, Martina Vasakova, Monika Žurková, Margita Bučeková, Martina Doubková, Marina Roksandic Milenkovic, Vladimir Bartos, Daniel Doležal, Martina Sterclova, Jaroslav Lněnička, Jana Psikalova, Pawel Sliwinski, Amelia Szymanowska-Narloch, Zsuzsanna Szalai, Veronika Müller, Jana Strenková, Ján Plutinský, Sebastian Majewski, Lenka Šišková, Dragana Jovanovic, Tomáš Snížek, Radka Bittenglova, Jiří Homolka, František Petřík, Pavlina Musilova, Hana Suldova, Martina Plačková, Vladimír Řihák, Ilona Binková
Publikováno v:
Diffuse Parenchymal Lung Disease.
Aims: Many patients with idiopathic pulmonary fibrosis (IPF) have a delay in diagnosis and thus also in treatment. We investigated whether such delay influenced survival and treatment response to pirfenidone and nitedanib. Methods: The retrospective
Autor:
Vladimíra Lošťáková, Peter Paluch, František Petřík, R. Hrdina, Monika Žurková, Pavel Reiterer, Pavlina Musilova, Renata Králová, Richard Tyl, Jana Psikalova, Tomáš Snížek, Lenka Šišková, Jana Strenková, Ladislav Lacina, Vladimir Bartos, Jiří Homolka, Martina Vasakova, Radka Bittenglova, Pavlína Lisá, Jan Švancara, Martina Plačková, Hana Hortvíková, Martina Sterclova, Martina Doubková, Hana Suldova, Zdeněk Merta, Vladimír Řihák, Ilona Binková, Michal Svoboda, Jaroslav Lněnička
Publikováno v:
The clinical respiratory journal. 12(4)
Prognostic factors of idiopathic pulmonary fibrosis (IPF) currently recognized include changes in vital capacity and radiologic findings. However, most of the prognostic studies in IPF are based on clinical studies with preselected IPF populations. T
Autor:
Jiri Homolka, Vladimir Rihak, Ladislav Lacina, Vladimira Lostakova, Gustav Ondrejka, Jana Psikalova, Frantisek Petrik, Martina Plačková, Vladimir Bartos, Michal Svoboda, Hana Suldova, Athol U. Wells, Martina Sterclova, Jaroslav Lnenicka, Martina Vasakova, Jan Kervitzer, Monika Zurkova, Jana Strenková, Radka Bittenglova, Martina Doubková, Pavlína Lisá, Renata Králová, Richard Tyl, Tomas Snizek
Publikováno v:
1.5 Diffuse Parenchymal Lung Disease.
AIMS: Idiopathic pulmonary fibrosis (IPF) is characterized by radiologic pattern of usual interstitial pneumonia (UIP) with honey-combing reflecting end-stage of the disease. Nevertheless significant part of patients with IPF does not present with ty
Autor:
Jana Psikalova, Monika Zurkova, Vladimir Rihak, Vitezslav Kolek, Tomas Snizek, Jaroslav Lnenicka, Martina Doubková, Martina Plačková, Vladimira Lostakova, Vladimir Bartos, Martina Vasakova, Pavlína Lisá, Frantisek Petrik, Renata Králová, Richard Tyl, Jana Strenková, Radka Bittenglova, Gustav Ondrejka, Michal Svoboda, Eva Kriegova, Hana Suldova, Ilona Binková, Ladislav Lacina, Martina Sterclova, Jiri Homolka, Jan Kervitzer
Publikováno v:
1.5 Diffuse Parenchymal Lung Disease.
Aims and objectives: The aim of the study was to compare the annual declineof lung functions during treatment with pirfenidone in comparison to triple-combination and other treatment modalities in Czech patients with IPF. Methods: Currently, the Czec